Cyproheptadine Alternatives Compared
| Cyproheptadine | Ubrelvy | Sumatriptan |
|
|---|
| Cyproheptadine | Ubrelvy (ubrogepant) | Sumatriptan |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Anorexia, Anorexia Nervosa, Allergic Rhinitis, Allergic Reactions, Cluster Headaches, Cushing's Syndrome, Migraine, Pruritus, Urticaria. May also be prescribed off label for Failure to... View more |
Prescription only
Ubrelvy may be used to treat acute migraine attacks in adults and works by blocking the effects of a protein, called CGRP that is thought to play a role in migraine attacks by causing pain, dilation... View more |
Prescription only
Sumatriptan may be used to quickly relieve the symptoms of a migraine but may not be suitable for everyone including those with pre-existing cardiovascular conditions. Prescribed for Cluster... View more |
Related suggestions Migraine
Popular comparisons
|
|||||||||||||||||||||||
| More about Cyproheptadine | More about Ubrelvy (ubrogepant) | More about Sumatriptan | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
|
No lower-cost generic available |
||||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Cyproheptadine has an average rating of 8.2 out of 10 from a total of 213 ratings on Drugs.com. 76% of reviewers reported a positive effect, while 10% reported a negative effect. |
Ubrelvy has an average rating of 5.9 out of 10 from a total of 219 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 42% reported a negative effect. |
Sumatriptan has an average rating of 7.7 out of 10 from a total of 538 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: cyproheptadine side effects in more detail. |
See also: Ubrelvy side effects in more detail. |
Commonly reported side effects include:
See also: sumatriptan side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all cyproheptadine prices |
View all Ubrelvy prices |
View all sumatriptan prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
N/A |
Imitrex, Imitrex Nasal, Imitrex Statdose, Onzetra Xsail, Tosymra, Zembrace SymTouch | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
16 hours |
7 hours |
6 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 323 drugs are known to interact with cyproheptadine:
|
A total of 209 drugs are known to interact with Ubrelvy:
|
A total of 91 drugs are known to interact with sumatriptan:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
October 17, 1961 |
December 23, 2019 |
January 28, 2016 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.